Investigating non-neurotropic viral infection and interleukin 34-mediated neuroprotection in alzheimer's disease

Active Grant Awarded

Award ID
FAG102009UZV6N5
Recipient
Awarding agency
Obligated
$43,715

Award facts

Assistance listing
93.AG4 National Institute on Aging Training Individual Projects
Completion date 1% complete
Place of performance
Durham, NC 27708, USA

Award details come from USAspending.gov.

Description

Abstract
Neuroimmune interactions are a critical link between environmental exposures and brain function and are implicated in nearly all neurologic diseases, including alzheimer's disease (ad). Microglia, the resident macrophages of the central nervous system, play a central role in these interactions, yet the long-term effects of peripheral immune challenges on microglial function and ad pathogenesis remain poorly understood. Recent studies have directly implicated multiple neurotropic viruses in ad pathogenesis, and emerging evidence suggests that aberrant immune responses, rather than the viruses themselves, may lead to ad progression. The priming of microglia by acute immune challenges, including non-neurotropic viral infections, influences their response to subsequent stimuli and is thought to contribute to dysfunctional proinflammatory phenotypes, like those of disease-associated microglia (DAMS) in ad. Signaling through the colony-stimulating factor 1 receptor (CSF1R) is linked to ad and may modulate microglial response to immune challenges. Notably, expression of the two known ligands of CSF1R, CSF-1 and interleukin 34 (IL-34), is dysregulated in ad: postmortem studies have found increased CSF-1 and decreased IL-34 expression in brain tissue from ad patients, and CSF-1 expression is commonly upregulated in DAMS. Recent work from our lab demonstrates that IL-34 signaling promotes microglial homeostasis during cortical development, and preliminary data suggests that hippocampal IL-34 overexpression may be neuroprotective in aging. However, the effect of IL-34 signaling on microglial response to inflammatory challenge and neurodegeneration remain unknown. This proposal will leverage microglial fate mapping, transcriptomic profiling, and viral IL-34 overexpression in the context of non-neurotropic influenza a infection in a mouse model of ad to test the hypothesis that acute influenza infection causes long- lasting changes in microglial function that influence ad pathology, and that neuronal IL-34 signaling is protective against these changes. Findings from this work will elucidate how common environmental exposures shape lifelong brain health, contribute to the identification of novel therapeutic targets, and inform future strategies for ad prevention.

Quick answers

Who received award FAG102009UZV6N5?

FAG102009UZV6N5 was awarded to Duke University by National Institute on Aging (National Institutes of Health) on November 18, 2026.

How much is award FAG102009UZV6N5 worth?

$43,715 has been obligated on FAG102009UZV6N5.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award